Sunday, October 30, 2016
1:00 p.m. – 5:00 p.m.
This session provides guidance to medication assisted treatment (MAT) professionals on how to work collaboratively with partners to engage and treat pregnant women with opioid use disorders. The presentation will provide guidance on collaboration gleaned from the National Center on Substance Abuse and Child Welfare’s (NCSACW) publication, The Collaborative Approach to the Treatment of Pregnant Women with Opioid Use Disorders. The session will further describe tactics used by two states engaged in the NCSACW two-year In-Depth Technical Assistance (IDTA) initiative on Substance Exposed Infants. The initiative, currently serving six states, is strengthening the capacity of states to serve pregnant women with substance use disorders, particularly those with opioid use disorders and their infants with Neonatal Abstinence Syndrome (NAS). Through the initiative, state partners deepened their understanding of barriers that impede or deter women and infants from receiving care. With technical assistance from the NCSACW, state partners created practice, policy, and protocol changes for effective cross-system service delivery for these women and infants.
Leaders from New Jersey and Virginia will describe how they worked with state MAT providers through the initiative to build communication and information sharing processes with hospitals, home visitors, and child welfare agencies to create a continuum of care for pregnant women and their children. Both states will discuss their work to increase the use of best cross-system practices such as intensive case management, leading to an increase in the engagement of pregnant and post-partum women in services and an increase in the identification of substance-exposed infants and their engagement in early intervention services.
Sponsored by the Substance Abuse and Mental Health Services Administration (SAMHSA)